Sort   by:  
 Page size 
UnknownAssessing Urinary Para-Hydroxyphenylacetic Acid as a Biomarker Candidate in Neuroendocrine Neoplasms.
Not available
S-EPMC11594794 | biostudies-literature
UnknownHDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation.
Not available
S-EPMC8892808 | biostudies-literature
UnknownEmerging Targeted Therapeutic Strategies to Overcome Imatinib Resistance of Gastrointestinal Stromal Tumors.
Not available
S-EPMC10094678 | biostudies-literature
UnknownTargeting the Formyl Peptide Receptor type 1 to prevent the adhesion of ovarian cancer cells onto mesothelium and subsequent invasion.
Not available
S-EPMC6839174 | biostudies-literature
UnknownPrevalence and distribution of M-proteins in the oncologic population affected by solid tumor.
Not available
S-EPMC11263620 | biostudies-literature
UnknownRetro-inverso Urokinase Receptor Antagonists for the Treatment of Metastatic Sarcomas.
Not available
S-EPMC5430962 | biostudies-literature
UnknownTherapeutic Strategies Targeting Urokinase and Its Receptor in Cancer.
Not available
S-EPMC8833673 | biostudies-literature
UnknownStructure-function relationship of an Urokinase Receptor-derived peptide which inhibits the Formyl Peptide Receptor type 1 activity.
Not available
S-EPMC6704176 | biostudies-literature
UnknownThe urokinase receptor-derived cyclic peptide [SRSRY] suppresses neovascularization and intravasation of osteosarcoma and chondrosarcoma cells.
Not available
S-EPMC5342356 | biostudies-literature
UnknownTargeting the cross-talk between Urokinase receptor and Formyl peptide receptor type 1 to prevent invasion and trans-endothelial migration of melanoma cells.
Not available
S-EPMC5721612 | biostudies-literature
Sort   by:  
 Page size